The 17th Annual Meeting of National Cervical Cancer Consortium & The Regional Conference of Asia Oceania Research Organization on Genital Infections and Neoplasia

17th NCCC & AOGIN 2019

第十七次全国子宫颈癌协作组工作会议 (17th NCCC)

暨亚洲 - 大洋洲生殖道感染和肿瘤研究组织区域大会( AOGIN 2019

Conference Agenda

大会日程

R egistr ation | 会议注册 3:00pm-10:00pm, April 26   7 :00 am –10:00am , April 27

Van ue | 注册地点:       West Hall of Beijing International Hotel (First Floor)   北京国际饭店西门大厅 ( 一层 )

April 27,2019 (Saturday) | 2019 4 27 日(星期六) | [Ballroom, 国际厅 ]

8:00am–8:20am

17th NCCC Consortium Leadership Meeting by Invitation

第十七次全国子宫颈癌协作组领导会议

Session 1: Opening & NCCC Consortium Annual Report

第一单元:开幕式及宫颈癌协作组年度总结报告

Chairs: Prof. Ai-Di Xu,

Prof. Xian-Zhi Duan

主持人:徐爱娣教授 段仙芝教授

8:30am-8:50am

Welcome Remarks

致欢迎辞

Representatives

领导致辞

8:50am-9:10am

Cancer Prevention Strategies in China

中国癌症防治策略

Prof. Ping Zhao, CFC

赵平教授 中国癌症基金会

9:10am-9:30am

Progress of Cervical Cancer Screening Program in China

中国子宫颈癌筛查项目进展

Li Song, Deputy Director, Maternal and Child Health Bureau, National Health Commission

宋莉副司长,国家卫健委妇幼健康司

9:30am-9:50am

Primary Prevention for Cervical Cancer in China

中国宫颈癌一级预防策略

Zheng-Long Lei, Deputy Director, Disease Prevention and Control Bureau, National Health Commission

雷正龙副局长,国家卫健委疾控局

9:50am-10:10am

NCCC Consortium Annual Report

子宫颈癌协作组年度工作报告

Prof. You-Lin Qiao, CHCAMS

乔友林教授   医科院肿瘤医院

10:10am-10:30am

Tea/Coffee Break | 茶歇

All | 全体

Session 2: AOGIN Keynote Speeches &   Summary of Charity Activities on Woman`s Day by CFC

二单元:特邀学术报告与中国癌症基金会三八公益活动总结

Chairs: Prof.Fang-Hui Zhao

Prof. Geng-Li Zhao

主持人: 赵方辉教授、赵更力教授

10:30am-11:00am

Keynote Speech:

WHO Initiative towards the Elimination of Cervical Cancer

特邀报告:世界卫生组织全球消除宫颈癌计划

Dr. Nathalie Broutet

WHO 世界卫生组织

11:00am-11:30am

Keynote Speech:

Progress & Challenges in HPV Prevention

特邀报告: HPV 防控的进程和挑战

Dr. Eng-Hseon Tay

Thomson Women Cancer Centre

新加坡汤姆森妇女癌症中心

11:30am-11:45am

Summary of Charity Activities on Women’s Day

全国三八公益活动总结

Ms. Xiao-Xi Yao, CFC

姚晓曦副理事长 中国癌症基金会

11:45am-12:00pm

Award Ceremony for Charity Activities

公益活动颁奖

Ms. Xiao-Xi Yao, et al

姚晓曦副理事长等

Industry Sponsored Session [Sponsored by GSK]:

Overall Protective Effect of HPV Vaccine

专题讨论会【 GSK 】: HPV 疫苗总体保护效力研讨

C hair : Prof. You-Lin Qiao

主持人:乔友林教授

12:20pm-12:50pm

Worldwide Clinical Research and Application of Bivalent HPV Vaccine

二价 HPV 疫苗在全球和中国的临床研究及应用

Prof. Fang-Hui Zhao, CHCAMS

赵方辉教授 医科院肿瘤医院

12:50pm-1:20pm

Innovative Adjuvant Mechanism and its Key Role in Vaccine Development

创新佐剂机制及其在疫苗开发中的关键性作用

Dr. Hai-Wen Tang, GSK

唐海文 博士 , GSK

Session 3: Cervical Cancer Control — Update on Current Practice (1)

第三单元:宫颈癌防控 最新进展( 1

Chairs: 

Dr. Ann Chao,

Prof. Shu-Zhen Wang | 王淑珍教授

1:30pm- 2:00pm

Keynote Speech: Human Papillomavirus Vaccines – Recent Developments and Global Perspective

特邀报告: HPV 疫苗 - 最新进展及全球展望

Dr. Peter Dull

Bill and Melinda Gates Foundation

比尔及梅琳达盖茨基金会

2:00 pm -2:20 pm

Worldwide Research Progress of Primary Prevention of Cervical Cancer

宫颈癌一级防控及 HPV 疫苗全球及中国研究进展

Prof. Li-Hui Wei

Peoples`s Hospital of Peking University

魏丽惠教授,北大人民医院

2:20pm-2:40pm

Efficacy of Single Dose of HPV Vaccine – Updated Results from Indian Trial

单剂 HPV 疫苗的有效性 - 印度最新研究结果

Dr. Partha Basu, WHO/IARC

世界卫生组织 / 国际癌症研究署

2:40pm-3:00pm

Clinical Evaluation of HPV Vaccine

HPV 疫苗的临床评估

Prof. Chen Yao, Peking University Health Science Center

姚晨教授,北京大学医学部

3:00pm-3:10pm

Questions & Answers

提问讨论

All Speakers and Chairs

所有讲者和主持人

3:10pm-3:30pm

Tea/Coffee Break | 茶歇

All | 全体

Session 4: Cervical Cancer Control — Update on Current Practice (2)

第四单元:宫颈癌防控 最新进展( 2

Chairs:

Prof. Hextan Ngan,

Prof. Jiu-Ling Wu 吴久玲教授

3:30pm-4:00pm

Keynote Speech: Scaling up HPV Cervical Cancer Screening in Central America

特邀报告: HPV 筛查在中美洲的建立

Dr. Silvia de Sanjose, PATH

美国适宜卫生技术研究院

4 : 00pm-4 : 20pm

Exploration of New Methods for Serological HPV Evaluation

HPV 血清学评价新方法探索

Prof. You-Chun Wang

National Institute for Food and Drug Control

王佑春教授 , 中国食品药品检定研究院

4:20pm-4:40pm

Economic evaluations of HPV vaccination in LMICs

中低收入国家 HPV 疫苗卫生经济学评价

Dr. Raymond Hutubessy, WHO  世界卫生组织

4:40pm-5:00pm

ROSE (Removing Obstacles to cervical Screening)- from Pilot to Program towards Eliminating Cervical Cancer in Malaysia

ROSE( 消除宫颈筛查的障碍 )- 马来西亚从试点到消除宫颈癌的项目实践

Prof. Yin Ling Woo

University of Malaya, Malaysia

马来西亚马来亚大学

5:00pm-5:10pm

Questions & Answers

提问讨论

All Speakers and Chairs

所有讲者及主持人

Welcome Reception | 欢迎招待会

Chair: Prof. Fang-Hui Zhao

主持人:赵方辉教授

5:20pm-5:30pm

Welcome Remarks | 欢迎辞

Prof. Fang-Hui Zhao | 赵方辉教授

 

Opening Lectures | 学术演讲

5:30pm-6:00pm

What will it take to eliminate cervical cancer?

如何消除宫颈癌?

Prof. Suzanne Garland

University of Melbourne

澳大利亚墨尔本大学

6:00pm-6:30pm

Building Partnerships for Global Cervical Cancer Prevention and Control

建立全球宫颈癌防控合作关系

Dr. Edward Trimble

National Cancer Institute, USA

美国国家癌症研究所

6:30pm-7:00pm

Opening Performance | 表演

7:00pm-8:30pm

Welcome Reception | 招待会

April 2 8 ,2019 (S un day) | 2019 4 28 日(星期 | [Ballroom, 国际厅 ]

Session 5: Comprehensive Prevention of Cervical Cancer

第五单元:宫颈癌综合防控

Chairs:

Dr . Wisit Supakarapongkul,

Dr. Efren Domingo

8:20am –8:50am

Keynote Speech: HPV and Cancer: from Discovery to Elimination

特邀报告: HPV 和宫颈癌:从发现到消除

Dr. Xavier Bosch Jose

Catalan Institute of Oncology

西班牙加泰罗尼亚肿瘤研究所

8:50am –9:10am

Impact and Safety of HPV Vaccination

HPV 疫苗的影响及安全性

Prof. Maggie Cruickshank

University of Aberdeen

英国阿伯丁大学

9:10am –9:30am

Implementation and Sustainability of Novel Cervical Cancer Control Actions: Examples from the Nordic Region

新型宫颈癌控制行动的实施和持续性:来自北欧地区实例

Dr. Mari Nygard

The Cancer Registry of Norway

挪威癌症登记中心

9:30am –9:50am

Prospects for Cervical Cancer Elimination as a Public Health Problem in the Region and Globally

消除宫颈癌作为区域和全球公共卫生问题的前景

Prof. Karen Canfell

Cancer Council NSW

澳大利亚新南威尔士癌症协会

9:50am – 10:10am

HPV Testing in Primary Cervical Screening in a Well Screened Chinese Population

HPV 检测作为宫颈癌初筛方法在中国人群中的应用

Dr. Karen Chan

The University of Hong Kong

香港大学

10:10am– 10:20am

Questions & Answers

提问讨论

All Speakers and Chairs

所有讲者和主持人

10:20am–10:40am

Tea/Coffee Break | 茶歇

All  全体

Session 6 Primary Prevention of Cervical Cancer Related Disease

第六单元 : 全方位视角看一级预防在宫颈癌防控中的地位

Chairs: Prof. Hua-Qing Wang,

Prof. Li-Hui Wei

主持人:王华庆教授、魏丽惠教授

10:40am–11:00am

Comparative Analysis of HPV Epidemics between China and Other Countries

HPV 感染流调数据中外对比及分析

Prof. Fang-Hui Zhao, CHCAMS

赵方辉教授,医科院肿瘤医院

11:00am–11:20am

Diversification of HPV Vaccination Accessibility

HPV 疫苗接种可及性的多样化

Prof. Ai-Qiang Xu

CDC of Shandong Province

徐爱强教授,山东省疾控中心

11:20am–11:40am

Clinical Application of HPV Vaccine among Specific Population

HPV 疫苗特殊人群中的临床应用

Prof. Long Sui, 

Obstetrics and Gynecology Hospital of Fudan University

隋龙教授,复旦大学附属妇产科医院

Panel Discussion | 专题讨论

Chairs: Prof. You - Lin Qiao ,

Prof Lin-Hong Wang

主持人:乔友林教授、王临虹教授

11:40am–11:55am

Discussion on the Present Situation and Challenges regarding to the Epidemiological Methodology by Experts in Different Fields

不同领域专家针对流调方法现状与挑战的探讨

Experts:

Profs. You-Lin Qiao, Fang-Hui Zhao, Li-Hui Wei, Lin-Hong Wang, Hua-Qing Wang, Ai-Qiang Xu, Long Sui

专家:乔友林、赵方辉、魏丽惠、王临虹、王华庆、徐爱强、隋龙教授等

11:55am- 12:10pm

How to Better Combine Primary and Secondary Prevention of Cervical Cancer among Adult Women to Achieve Best Cost-effectiveness

成年女性如何更好的结合宫颈癌一级、二级预防达到最佳成本效益

Industry Sponsored Session & Lunch

[Sponsored by Roche & HOLOGIC & SENYING BIO-TECH]

企业发起专题会及午餐【罗氏、豪洛杰、森盈生物】

Chair: Prof. You-Lin Qiao

主持人:乔友林教授

12:20pm-12:50pm

Health Economics Evaluation of Optimized Cervical Cancer Screening Program

宫颈癌筛查优化方案的卫生经济学评估

Prof. Li-Hui Wei

Peoples`s Hospital of Peking University

魏丽惠教授,北大人民医院

12:50pm-1:20pm

Innovation in HPV Detection Technology From DNA to RNA

HPV 诊断技术革新 —— DNA RNA

Prof. Fang-Hui Zhao, CHCAMS

赵方辉教授,医科院肿瘤医院

1:20pm-1:50pm

The Application of PathCIN p16 in Primary and Triage Screening of Cervical Cancer

细胞学 p16 在宫颈癌初筛及分流的应用价值

Prof. Qin-Jing Pan, CHCAMS

潘秦镜教授,医科院肿瘤医院

Session 7: Screening & Management — Implementation, Evaluation and Impact (1)

第七单元 : 宫颈癌筛查和管理 实施、评估及影响 (1)

Chairs: Prof. Annie N.Y. Cheung

Prof. Yun Zhao 赵昀教授

2:00pm – 2:30pm

Keynote Speech: HPV Assays that Fulfil Requirements for Cervical Cancer Screening

特邀报告:可满足宫颈癌筛查需求的 HPV 检测方法

Prof. Marc Arbyn

Belgian Cancer Centre, Sciensano

比利时癌症研究中心

2:30pm – 2:50pm

Development of HPV Screening Technologies in China

我国宫颈癌 HPV 检测技术进展

Prof. Chun-Tao Zhang, National Institutes for Food and Drug Control

张春涛教授,中国食品药品检定研究院

2:50pm – 3:10pm

Outcome of Colposcopy Services in First Year of National Primary HPV Screening

国家 HPV 初筛策略第一年阴道镜结果

Dr. Jeffrey Tan

Royal Women’s Hospital, Melbourne

澳大利亚墨尔本皇家妇女医院

3:10pm – 3:30pm

Portable Colposcopes and the Quest for Elimination of Cervical Cancer

便携式阴道镜及宫颈癌消除的探索

Dr. Neerja Bhatla

All India Institute of Medical Sciences

印度医学科学研究所

3:30pm – 3:50pm

Using Surrogate Measures of Anal Cancer Risk to Identify High-risk Groups for Secondary Anal Cancer Prevention

应用肛门癌风险替代指标识别高危人群进行肛门癌二级预防

Dr. Gary Clifford, WHO/IARC

世界卫生组织 / 国际癌症研究署

3:50pm – 4:10pm

Preventing anal Cancer in Women

女性肛门癌防控

Dr. Richard Hillman

St Vincent’s Hospital, Sydney

澳大利亚 悉尼 St Vincent's 医院

4:10pm – 4:20pm

Questions & Answers

提问讨论

All Speakers and Chair

所有讲者和主持人

4:20pm – 4:30pm

Closing Remarks | 闭幕式

April 2 8 ,2019 (S un day) | 2019 4 28 日(星期 | [Rainbow Room 彩虹厅 ]

Session 8: Screening & Management — Implementation, Evaluation and Impact  (2)

第八单元 : 宫颈癌筛查和管理 实施、评估及影响 (2)

Chairs: Dr Chin Pui See,

Prof. S huang Li 李双 教授

8:20am –8:50am

Keynote Speech: Cervical Cancer Treatment

特邀报告:宫颈癌的治疗

Prof . Hextan Ngan

The University of Hong Kong

香港大学

8:50am –9:10am

National Strategy for Cervical Cancer Prevention and Control in Bangladesh, 2017-2022

2017-2022 年孟加拉国宫颈癌防控策略

Prof. Ashrafun Nessa

Bangabandhu Sheikh Mujib Medical University (BSMMU)

孟加拉 Sheikh Mujib 医科大学

9:10am –9:30am

Integrated Application of HPV Assays in Cytology for Cervical Cancer Detection

HPV 联合细胞学检查在宫颈癌筛查中的应用

Prof. Annie N.Y. Cheung

The University of Hong Kong

香港大学

9:30am –9:50am

Structural vaccinology based rational design for next generation HPV vaccine

采用结构疫苗学策略的新一代宫颈癌疫苗的理性设计

Prof. Shaowei Li

Xiamen University

李少伟教授,厦门大学

9: 5 0am – 10 : 1 0am

Could HPV be transmitted through blood?

HPV 可否通过血液传播

Prof. Tang-Yuan Chu

Tzu Chi Medical Center, Taiwan

台湾慈济综合医院

10:10am–10:20am

Questions & Answers | 提问讨论

All Speakers and Chair

所有讲者和主持人

10:20am– 10:40am

Tea/Coffee Break 茶歇

All | 全体

Session 9: Development of HPV Screening Assays

第九单元: HPV 筛查技术进展

Chairs:

Prof. Wen Chen 陈汶教授

Prof. Chun-Tao Zhang 张春涛教授

10:40am-10:55am

An Integrated Self-Sampling-Based WeTest)Approach to HPV Test

基于自采样(微采)的 HPV 检测综合解决方案

Mr. Walter Zhang, Shanghai ZJ Bio-Tech Co.,Ltd

张先东先生,上海之江生物科技股份有限公司

10:55am–11:10am

3G Hybrid Capture and Cervical Cancer Screening

第三代杂交捕获技术与宫颈癌筛查

Dr. Shao-Bing Hua

Hangzhou Dalton Bio

华绍炳博士,杭州徳同生物技术有限公司

11:10am–11:25am

Clinical Performance of Microfluidic Automatic Nucleic Acid Detection System in Cervical Cancer Screening

微流控全自动核酸检测系统在宫颈癌筛查中临床效果研究

Prof. Fang-Hui Zhao, CHCAMS

赵方辉教授,医科院肿瘤医院

11:25am-11:40am

硕世同步 HPV 分型及定量检测的临床价值

Clinical Value of Bioperfectus HPV Genotyping and Quantitative Detection

Prof. Peng-Ming Sun

Fujian Provincial Maternity

and Children s Hospital

孙蓬明教授 , 福建省妇幼保健院

11:40am-11:55am

Advances in Cervical Cancer Screening and Management: Performance of HPV Extended Genotyping in the

US Clinical Trial

宫颈癌筛查和管理进展:在美国临床试验中 HPV 扩展基因分型检测的临床效果

Dr. Jeffrey Andrews, BD

美国 BD 公司

11:55am-12:10pm

careHPV A Bridge to a Dream

careHPV 通往理想的桥梁

Julie Zhu

careLYFE | 凯爱健康科技有限公司

12:20pm-1:50pm

Lunch Seminar at Ballroom | 午餐报告会(国际厅

Session 10: Best Paper Presentation

第十单元:优秀论文汇报

Chairs:

Prof. Dejana Braithwaite

Prof. Zhu-Mei Cui 崔竹梅教授

2:00pm – 2:10pm

AS04-adjuvanted HPV-16/18 Vaccine Elicits Long-lasting Immune Response in 9- to 17-year-old Chinese Girls

AS04- 佐剂 HPV-16/18 疫苗在 9-17 岁中国女孩中的长期免疫应答

Prof. Yue-Mei Hu

Jiangsu Province Center for Disease Control and Prevention

胡月梅教授,江苏省疾控中心

2:10pm – 2:20pm

Single Infection of HPV16 is Associated with a Higher Risk of Cervical Cancer and CIN3 than Multiple Infection

单重感染 HPV 16 CIN3 和宫颈癌风险高于多重感染

Prof. Li Geng

Peking University Third Hospital

耿力教授,北京大学第三医院

2:20pm – 2:30pm

Systematic Literature Review of Neutralizing Antibody Immune Responses to Non-vaccine High-risk HPV Types Induced by the Bivalent and the Quadrivalent Vaccines

二价疫苗和四价疫苗对非疫苗高危 HPV 型别的抗体免疫应答中和作用的系统综述

Alfred Saah

Merck Sharp & Dohme Corp. 

默沙东(中国)投资有限公司

2:30pm – 2:40pm

Comparison of Five Different Commercial Kits for the Detection and Genotyping of Human Papillomavirus

五种 HPV 检测和分型试剂盒对比分析结果

Prof. Ya-Bin Tian

Division II of In Vitro Diagnostics for Infectious Diseases, National Institutes for Food and Drug

Control

田亚宾教授,中国食品药品检定研究所传染病体外诊断二室

2:40pm – 2:50pm

Selecting an Optimal Combination of Bivalent HPV Vaccination and Screening Strategies against Cervical Cancer in China

选择适宜中国的二价 HPV 疫苗和宫颈癌筛查优化组合

Chang-Fa Xia, PhD, CHCAMS

夏昌发博士,医科院肿瘤医院

2:50pm – 3:00pm

Human Papillomavirus Genotype Distribution among Cervical Cancer Cases in the Asia-pacific Region

亚太地区宫颈癌患者中 HPV 型别分布

Stefan Varga

Merck Sharp & Dohme Corp.

默沙东(中国)投资有限公司

3:00pm – 3:10pm

Distribution of High Risk-Human Papillomavirus Genotype Prevalence and Attribution to Cervical Cancer and Precancerous Lesions in Chinese Rural Women

中国农村妇女高危型 HPV 型别分布及其与宫颈癌及癌前病变的关系

Shuang Zhao, PhD, CHCAMS

赵爽博士,医科院肿瘤医院

3:10pm – 3:20pm

Variable Cross-Protection Effect of HPV Vaccine from a Systematic Literature Review

HPV 疫苗交叉保护作用的系统综述

Alain Luxembourg

Merck Sharp & Dohme Corp.

默沙东(中国)投资有限公司

3:20pm – 3:30pm

Comparison of Clinical Accuracy between GenplexHPV, CobasHPV, careHPV and Liquid-based Cytology in Diagnosis of Cervical Precancerous and Cancerous Lesion

GenplexHPV CobasHPV careHPV 与液基细胞学诊断宫颈癌前病变和宫颈癌的临床准确性比较分析

Ru-Fei Duan, PhD, CHCAMS

段如菲博士,医科院肿瘤医院

3:30pm – 3:40pm

Efficacy of AS04-HPV16/18-vaccine against High-grade Cervical Lesions Irrespective of HPV Type: From Clinical Trials to Real-world Data

AS04-HPV16/18 疫苗对不同 HPV 型别所致宫颈病变的治疗效果:从临床试验到真实世界研究

Valérie Berlaimont, PhD

Global Medical Affairs,

GSK China Ltd.

葛兰素史克(中国)投资有限公司全球医学事务部

4:20pm – 4:30pm

Closing Remarks at Ballroom | 闭幕式(国际厅